Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?

6Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The term host defense peptides arose at the beginning to refer to those peptides that are part of the host’s immunity. Because of their broad antimicrobial capacity and immunomodulatory activity, nowadays, they emerge as a hope to combat resistant multi-drug microorganisms and emerging viruses, such as the case of coronaviruses. Since the beginning of this century, coronaviruses have been part of different outbreaks and a pandemic, and they will be surely part of the next pandemics, this review analyses whether these peptides and their derivatives are ready to be part of the treatment of the next coronavirus pandemic.

Cite

CITATION STYLE

APA

Rivas-Santiago, B., Jacobo-Delgado, Y., & Rodriguez-Carlos, A. (2021, December 1). Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic? Archivum Immunologiae et Therapiae Experimentalis. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00005-021-00630-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free